iWHELD Program Improves QoL for People With Dementia in Nursing Homes
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Dec. 26, 2023 -- A digital person-centered care program (iWHELD) for people with dementia in nursing homes, adapted for remote delivery during the COVID-19 pandemic, is beneficial for improving quality of life and key measures of well-being, according to a study published online Dec. 20 in Alzheimer's & Dementia.
Joanne McDermid, from the University of Exeter Medical School in the United Kingdom, and colleagues conducted a 16-week cluster-randomized trial involving 739 nursing home residents with dementia in 149 U.K. nursing homes to compare iWHELD (Improving Well-being and Health for People With Dementia) to treatment as usual for quality of life. Secondary outcomes included agitation and psychotropic use.
The researchers found that iWHELD conferred benefit on the primary and secondary measures of quality of life and reduced use of psychotropic medication with no indication of worsening of agitation. Participants who contracted COVID-19, those with agitation at baseline, and those taking psychotropic medication experienced benefit.
"These findings emphasize the potential of iWHELD to address critical needs in diverse nursing home settings, positioning it as a valuable intervention to enhance the well-being and care outcomes of residents of participating homes," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-27 06:15
Read more
- Lower Risk for Asthma Seen With Younger Age at Natural Menopause
- ACAAI: ICS + Formoterol and ICS + SABA Better Than SABA Alone for Asthma
- Obesity-Linked Heart Deaths Nearly Tripled in U.S. Over Past Two Decades
- The Right Time is Now to Get Your Flu Vaccine
- Breast Cancer Risk Elevated With Levonorgestrel-Releasing Intrauterine System Use
- Oct. 7 Tragedy Spurs Israeli Researcher to Study Grief Over Sibling Loss
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions